None listed
Conditions
Brief summary
Hepatitis B serology will be measured in children born to hepatitis B carrier mothers. Those with low immunity will be given a booster dose of hepatitis B vaccine and have their immunity measured post vaccination
Interventions
Hepatitis B serology at baseline
Response to a booster dose of hepatitis B vaccine
HBVaxII 10microgram intramuscularly
Sponsors
National Centre for Immunisation Research and Surveillance
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Prevention
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
10 Years to 19 Years
Healthy volunteers
No
Inclusion criteria
Adolescents born to hepatitis B carrier mothers.
Exclusion criteria
Mother not a hepatitis B carrierAll participants have hepatitis B serology at baselineOnly adolescents with HBsAb <10IU/ml given a booster dose of vaccine.
Outcome results
None listed